In this episode of the UEG Talks conversation between Maria Vehreschild and Pradeep Mundre, we delve into the complexities of the faecal microbiome and the role of faecal microbiota transplantation (FMT) in treating various diseases, particularly C. difficile infections and inflammatory bowel disease (IBD). The discussion covers the historical context of FMT, its mechanisms of action, current treatment guidelines, safety considerations, and the various delivery methods. The conversation also emphasises the need for further research and the importance of professional standards in FMT practices.
Trending
- Private equity owns less than 4% of U.S. hospitals, study finds (Medical Xpress)
- FIT Misses More CRCs in Women; Could Sex-Specific Thresholds Help? (HCP Live)
- Greg O’Grady: The Surgeon Who Left Surgery to Map the Stomach (Gut Health Times)
- GI Practices Lose More on Second Procedures Than Any Other Specialty, Jiro Health Benchmark Finds (PR Newswire)
- Throne Announces First Clinical Validation Study, Demonstrating Its AI-Powered Stool Classification Performs Comparably to Board-Certified Gastroenterologists (Business Wire)
- Blood-Based Colorectal Cancer Screening Averts More Deaths Than Stool Tests, Modeling Shows (Clinical Lab Products)
- For Better or Worse, Monitored Anesthesia Care Is Now the Default in GI Endoscopy (GI & Endoscopy News)
- AI ‘may offer an efficient way’ to detect colorectal neoplasia, but more research needed (Healio)
